首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
microbiocidas
摘要
Compounds of formula (I) in which the substituents are as defined in claim 1, are suitable for use as microbiocides.
申请公布号
BRPI0911199(A2)
申请公布日期
2016.04.26
申请号
BR2009PI11199
申请日期
2009.04.17
申请人
SYNGENTA PARTICIPATIONS AG
发明人
DANIEL STIERLI;RAMYA RAJAN;WALTER HARALD
分类号
C07D231/14;A01N43/56
主分类号
C07D231/14
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Microprocessor with automatic selection of SIMD parallelism
SEAMLESS LOCATION AWARE NETWORK CONNECTIVITY
POLYPEPTIDE MARKER FOR DIAGNOSIS OF ARTERIOSCLEROSIS, METHOD FOR DETECTION OF ARTERIOSCLEROSIS BY USING THE MARKER OR THE LIKE, AND KIT FOR DIAGNOSIS OF ARTERIOSCLEROSIS
A SWITCH MODE CONVERTER AND A METHOD OF STARTING A SWITCH MODE CONVERTER
CAPAS DE SACCHAROMYCES CEREVISIAE CON APTITUDES FITOSANITARIAS
COMPOSICIONES PARA EL TRATAMIENTO DEL CABELLO.
DATA RECEIVING APPARATUS, DATA TRANSMITTING APPARATUS, METHOD FOR CONTROLLING THE SAME AND PROGRAM
Aircraft equipment support
Fixing device and image forming apparatus incorporating the fixing device
A METHOD FOR APPLICATION SELECTION IN A WIRELESS MOBILE COMMUNICATION DEVICE IN AN NFC SYSTEM AND A CORRESPONDING WIRELESS MOBILE COMMUNICATION DEVICE
COATING COMPOSITION FOR LOW REFRACTIVE LAYER, ANTI-REFLECTION FILM USING THE SAME, POLARIZER AND IMAGE DISPLAYING DEVICE INCLUDIG THE ANTI-REFLECTION FILM
UN DERIVADO DE CIANOPIRIMIDINA PARA EL TRATAMIENTO DE UNA ENFERMEDAD OCULAR
One-time band manufacture formation system
COMPOSICIONES Y METODOS PARA MEJORAR LA ESTABILIDAD DE ALIMENTOS, BEBIDAS, SUPLEMENTOS NUTRICIONALES Y COSMETICOS
UNIDAD SEPARADORA DE PEDUNCULOS UNIDOS ENTRE SI DE CEREZAS, MAQUINA PARA SEPARAR PEDUNCULOS UNIDOS ENTRE SI DE CEREZAS QUE LA COMPRENDE Y METODO PARA SEPARAR PEDUNCULOS UNIDOS ENTRE SI DE CEREZAS CON LAS MISMAS
UN CONDUCTO DE DOS CAPAS
A method of training and/or evaluating a vehicle safety algorithm
Process for the production of flat building materials
Cable trunking device
Peptide- or antibody-based immunization therapy for treatment of atherosclerosis targeting ApoB100
